Ashley Robert A. Insider Trades

Insider Trading History

Track insider trading activity for Ashley Robert A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunic
Immunic IMUX
Chief Scientific Officer, EVP
Holding Value $0 0 shares
Last Trade
Jan 11, 2019 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$85.8k 340,014 shares
$0.25
$14.43
Immunic
Immunic IMUX
Chief Scientific Officer, EVP
Holding Value $11.8M 816,634 shares
Last Trade
Jan 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 816,634 shares
$0.25
$14.43
Immunic
Immunic IMUX
Chief Technical Officer, EVP
Holding Value $1.08M 75,000 shares
Last Trade
Jun 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 75,000 shares
$5.00
$14.43
Immunic
Immunic IMUX
Chief Technical Officer, EVP
Holding Value $1.08M 75,000 shares
Last Trade
Jun 10, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 75,000 shares
$3.20
$14.43
Immunic
Immunic IMUX
Chief Technical Officer, EVP
Holding Value $28.9k 2,000 shares
Last Trade
Jun 09, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.36k 2,000 shares
$3.18
$14.43
Immunic
Immunic IMUX
See Remarks
Holding Value $1.08M 75,000 shares
Last Trade
May 13, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$621k 75,000 shares
$8.28
$14.43
Immunic
Immunic IMUX
See Remarks
Holding Value $0 0 shares
Last Trade
Apr 16, 2014 Sale
No data
No data
$14.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up